Tumors in TNBC are known to have hypermethylated DNA and consistent with this, we see enhanced methylation of several key CpG sites within the CREB3L1 gene that strongly correlate with reduced expression in breast cancer cell lines and in human breast tumors. This evidence concerns the gene CREB3L1 and breast cancer.